You are viewing: South Korea Vascular Stent Market analysis
Part of: Vascular Stent Market (Global)

The South Korea Vascular Stent Market was valued at $94.5 Million in 2024 and projected to reach to $133.8 Million by 2029, representing a compound annual growth rate of 7.2%. South Korea's vascular stent market is positioned for sustained expansion through 2029, driven by demographic shifts toward an older population and increasing cardiovascular disease burden.

South Korea Vascular Stent Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

South Korea Vascular Stent Market Trends and Insights

  • This represents a compound annual growth rate (CAGR) of 7.2%, outpacing global market expansion.
  • South Korea's advanced healthcare infrastructure, aging population, and rising prevalence of cardiovascular diseases are driving demand for innovative stent technologies across the country. The South Korean market benefits from strong government healthcare policies, high patient awareness, and significant investment in medical device innovation.
  • South Korea's healthcare system prioritizes cardiovascular interventions, supporting steady adoption of both bare-metal and drug-eluting stents.
  • Between 2024 and 2029, South Korea is expected to see increased competition among domestic and international manufacturers, alongside growing demand for minimally invasive procedures. South Korea's position as a regional medical technology hub enhances market accessibility and accelerates the introduction of cutting-edge vascular stent solutions.
  • The country's regulatory environment and reimbursement landscape continue to support market penetration, making South Korea a key growth market within the Asia Pacific region..

Key Market Statistics

  • CAGR (2024-2029) 7.2% CAGR
  • Market Size, 2024 ~USD 94.5 Million
  • Forecast, 2029 ~USD 133.8 Million
  • Country South Korea

South Korea Vascular Stent Market Overview

Market Valuation & Growth :

South Korea's vascular stent market reached USD 94.5 million in 2024, with a projected value of USD 133.8 million by 2029, representing a robust 7.2% CAGR that exceeds global growth rates.

Aging Population Dynamics :

South Korea's rapidly aging demographic, with increasing life expectancy, is driving higher incidence of cardiovascular diseases and creating sustained demand for advanced vascular stent interventions.

Healthcare Infrastructure Excellence :

South Korea's world-class healthcare system, advanced medical technology adoption, and high healthcare spending per capita support rapid uptake of innovative stent technologies and procedures.

Cardiovascular Disease Prevalence :

Rising prevalence of hypertension, diabetes, and lifestyle-related cardiovascular conditions in South Korea is accelerating the need for vascular interventions and stent placements across urban and rural regions.

South Korea Vascular Stent Market Dynamics

  • The country's sophisticated healthcare infrastructure and strong adoption of minimally invasive procedures support market growth.
  • Government healthcare policies and insurance coverage for stent procedures further enhance market accessibility and patient treatment rates. Innovation in drug-eluting stents, bioresorbable scaffolds, and next-generation technologies will shape competitive dynamics.
  • South Korean hospitals and interventional centers are increasingly investing in advanced imaging and procedural capabilities, supporting higher procedure volumes.
  • Strategic partnerships between local healthcare providers and international medical device manufacturers will accelerate market penetration and drive revenue growth through 2029..

Related Ecosystem

Key Takeaways

  • South Korea's vascular stent market is valued at USD 94.5 million in 2024 and is forecast to reach USD 133.8 million by 2029, growing at a 7.2% CAGR.
  • South Korea's aging demographic and high prevalence of cardiovascular disease are primary drivers of sustained market expansion through 2029.
  • South Korea's advanced healthcare infrastructure and strong regulatory framework position the country as a leading medical device market in Asia Pacific.
  • South Korea's market is characterized by increasing adoption of drug-eluting stents and bioresorbable vascular scaffolds, reflecting technological advancement.

Vascular Stent Market Report Scope

Report Metric Details
Base Year 2024
Fastest Growing Segment POLYMERIC MATERIALS (Material)
Forecast Period 2024-2029
Growth Rate CAGR of 6.5% from 2024 to 2029
Largest Segment METALLIC MATERIALS (Material)
Market Size Base Year (Billions) ~USD 11.39 (2024)
Revenue Forecast (Billions) ~USD 15.6 (2029)
Segments Covered Technology, Product, Type, Mode Of Delivery, Material, End User

South Korea Vascular Stent Market Report Segmentation

6 segment dimensions are covered across the global market.

By Technology

  • Bare Metal Stents
  • Bioabsorbable Stents
  • Covered Stents
  • Drug-Eluting Stents

By Product

  • Coronary Stents
  • Evar Stent Grafts
  • Peripheral Stents

By Type

  • Abdominal Aortic Aneurysm Stent Grafts
  • Biodegradable Polymers
  • Carotid Artery Stents
  • Cobalt Chromium
  • Femoral Artery Stents
  • Iliac Artery Stents
  • Nickel Titanium
  • Non-Biodegradable Polymers
  • Other Peripheral Stents
  • Platinum Chromium
  • Renal Artery Stents
  • Stainless Steel
  • Thoracic Aortic Aneurysm Stents Grafts

By Mode Of Delivery

  • Balloon-Expandable Stents
  • Self-Expanding Stents

By Material

  • Metallic Materials
  • Polymeric Materials

By End User

  • Cardiac Centers
  • Cardiac Centres
  • Hospitals

Target Audience

  • Medical Device Manufacturers : Manufacturers need South Korea-specific market data to develop localized product strategies, identify distribution partners, and optimize pricing for this high-value Asian market.
  • Healthcare Investors & PE Firms : Investors require detailed South Korea market analysis to evaluate investment opportunities in cardiovascular device companies, hospital networks, and healthcare technology providers.
  • Hospital & Clinic Administrators : Healthcare facility leaders need market insights to plan capital investments in interventional cardiology equipment, forecast procedure volumes, and optimize resource allocation.
  • Market Research & Consulting Firms : Research professionals require granular South Korea data to support client advisory projects, competitive benchmarking, and strategic planning initiatives in the cardiovascular sector.
  • Government & Policy Makers : Healthcare policymakers need market intelligence to inform reimbursement policies, healthcare infrastructure planning, and regulatory frameworks for cardiovascular interventions in South Korea.

Reasons to Buy this Report

  • Market-Specific Growth Projections : Access precise forecasts for South Korea's vascular stent market through 2029, enabling accurate business planning and investment decisions tailored to this high-growth Asian market.
  • Competitive Landscape Intelligence : Understand key players, market share distribution, and competitive strategies specific to South Korea's healthcare ecosystem and regulatory environment.
  • Demographic & Clinical Insights : Leverage data on South Korea's aging population, cardiovascular disease epidemiology, and treatment patterns to identify market opportunities and patient segments.
  • Regulatory & Reimbursement Analysis : Gain insights into South Korean healthcare policies, insurance coverage mechanisms, and regulatory pathways that influence stent adoption and market dynamics.
  • Strategic Market Entry Planning : Develop informed go-to-market strategies for South Korea with detailed market segmentation, distribution channels, and partnership opportunities specific to this region.

Frequently asked questions

What is the current size of South Korea's vascular stent market?

South Korea's vascular stent market was valued at USD 94.5 million in 2024 and is expected to grow to USD 133.8 million by 2029.

What is the projected growth rate for South Korea's vascular stent market?

South Korea's vascular stent market is projected to grow at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.

What factors are driving growth in South Korea's vascular stent market?

Key drivers include South Korea's aging population, rising cardiovascular disease prevalence, advanced healthcare infrastructure, strong government support, and increasing adoption of minimally invasive procedures.

Which stent types are most prevalent in South Korea's market?

South Korea's market shows strong adoption of drug-eluting stents and bioresorbable vascular scaffolds, alongside traditional bare-metal stents, reflecting the country's focus on advanced medical technologies.

How does South Korea's vascular stent market compare to global trends?

South Korea's market growth rate of 7.2% CAGR exceeds the global average of 6.5%, demonstrating stronger regional demand and market maturity within the Asia Pacific region.

RESEARCH METHODOLOGY

The study involved four major activities to estimate the current size of the vascular stent market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for the study of Vascular stent Market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

Extensive primary research was conducted after obtaining information regarding the vascular stent market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific,  Latin America, and the Middle East & Africa. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors from business development, marketing, product development/innovation teams, and related key executives from manufacturers; distributors operating in the Vascular stent market.; and key opinion leaders.

Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to technology, application, vertical, and region. Stakeholders from the demand side customers/end users who are using infection control products were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage and the future outlook of their business, which will affect the overall market.

The following is a breakdown of the primary respondents:

Breakdown of Primary Participants:

Vascular Stents Market Size, and Share

Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.

Note 2: Other primaries include sales managers, marketing managers, and product managers.

Note 3: Companies are classified into tiers based on their total revenue.

As of 2023: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=<USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The research methodology used to estimate the size of the vascular stent market includes the following details.

The market sizing of the market was undertaken from the global side.

Country-level Analysis: The size of the Vascular stent market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall vascular stent market was obtained from secondary data and validated by primary participants to arrive at the total vascular stent market. Primary participants further validated the numbers.

Geographic market assessment (by region & country): The geographic assessment was done using the following approaches:

Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall Vascular stent market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

Global Vascular stent Market Size: Top-Down Approach

Vascular Stents Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Global Vascular stent Market Size: Bottom-Up Approach

Vascular Stents Market Size, and Share

Data Triangulation

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Vascular stent industry.

Market Definition:

Vascular stents are metallic or polymeric meshes designed to apply uniform radial force within blood vessels, ensuring they remain open and function properly. These stents are implanted in the vascular system to maintain blood flow to the heart muscle.

Key Stakeholders

  • Vascular Stent Manufacturers
  • Various Research and Consulting Companies
  • Healthcare Institutions (Hospitals, Cardiac Centers, and Surgical Centers)
  • Vascular Stent Distributors and Suppliers
  • Contract Manufacturing Organizations (CMOs)
  • Pharmaceutical and medical device companies

Report Objectives

  • To define, describe, and forecast the vascular stent market based on technology, product, mode of delivery, material, end user, and region.
  • To strategically analyze the industry trends, technology trends, pricing analysis, regulatory scenario, supply/value chain, ecosystem mapping, porter’s five forces, patent analysis, key stakeholders and buying criteria, and conference and events.
  • To provide detailed information regarding the major factors influencing the growth of this market (such as drivers, restraints, opportunities, and challenges)
  • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall vascular stent market.
  • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders.
  • To forecast the market size based on six key regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
  • To strategically profile key players in the vascular stent market and comprehensively analyze their core competencies.
  • To track and analyze competitive developments such as product/service launches & approvals, partnerships, agreements, collaborations, joint ventures, expansions, and acquisitions in the overall vascular stent market.
  • To benchmark players within the market using the proprietary “Competitive Leadership Mapping” framework, which analyzes market players on various parameters within the broad categories of business and product/service strategy.
  • To analyze the impact of the recession on the vascular stent market.

Available Customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

  • Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company.
  • Geographic Analysis:  Further breakdown of the Latin American Vascular stent into specific countries and, the Middle East, and Africa Vascular stent into specific countries and further breakdown of the European Vascular stent into specific countries,

Get the Full Vascular Stent Market Report

Full forecast, segment splits, and company analysis for all Vascular Stent Market.

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report
Fact checked
DMCA.com Protection Status